Investing.com -- As investors look ahead to the first half of 2026, BTIG analysts have released their top stock picks across various sectors.
These selections represent companies with strong technical patterns and significant upside potential according to the firm’s research team.
Get premium news and insight, AI stock picks, and deep research tools by upgrading to InvestingPro - get 55% off today
BTIG’s analysis highlights stocks showing promising chart patterns, key support levels, and potential breakout opportunities. Here’s a closer look at their top recommendations:
1. BrightSpring Health Services, Inc. (BTSG): Analyst David Larsen assigns a Buy rating with a $50 price target. The stock has demonstrated a strong uptrend since summer, reaching new all-time highs. While some consolidation may occur, BTIG believes further upside is likely as long as it maintains support above its 50-day moving average of $34.43.
2. Compass, Inc. (COMP): With a Buy rating and $12.50 price target from analyst Jake Fuller, this stock has shown remarkable recovery after declining 90% from 2021 to 2023. Following a multi-year base formation, it broke out in November. BTIG sees good support in the $9-$9.50 range and projects potential upside to $14 if support holds.
Compass, Inc. reported strong third-quarter 2025 results with revenue of $1.85 billion, a 23.6% year-over-year increase, and record adjusted EBITDA of $93.6 million. Additionally, Barclays upgraded the company’s stock to Overweight, citing synergies from its acquisition of HOUS.
3. Edwards Lifesciences Corporation (EW): Analyst Marie Thibault rates it Buy with a $103 target. After a significant gap down in mid-2024, the stock has steadily recovered, filling the gap in November. Recent consolidation suggests another leg higher into the mid-$90s, with potential to reach $105-$110 if it clears the $95 level.
Edwards Lifesciences recently received FDA approval for its SAPIEN M3 mitral valve replacement system, the first transcatheter therapy of its kind. The company also saw an analyst upgrade to Overweight from JPMorgan.
4. Establishment Lab Holdings, Inc. (ESTA): Carrying an $86 price target from analyst Sam Eiber, this stock broke out in October/November and is now consolidating below $80. BTIG maintains a constructive outlook as long as support at $62-$64 holds.
Establishment Lab Holdings, Inc. has submitted an application to the FDA to expand the approved use of its Motiva implants to include breast reconstruction. Following the submission, BTIG raised its price target on the company to $86.00.
5. Harrow, Inc. (HROW): Analyst Thomas Shrader assigns a $63 target. After a strong run followed by a pullback in early 2025, the stock has been recovering. BTIG believes it could challenge its previous high around $59, with support in the low $40s offering potential buying opportunities.
Harrow, Inc. reported a third-quarter 2025 earnings per share of $0.33, beating forecasts, and also completed its acquisition of clinical-stage pharmaceutical company Melt Pharmaceuticals.
6. Klaviyo, Inc. (KVYO): With a $40 target from analyst Nick Altmann, this stock has been forming a base for the past year with a potential double bottom around $23. Having reclaimed its 200-day moving average, it faces resistance at $35-$37, but could run to $40-$50 if it breaks through.
In recent developments, Klaviyo, Inc. announced that its customers generated $3.8 billion in sales through its platform over the Black Friday weekend, a 27% year-over-year increase, and appointed Chano Fernández as co-CEO.
7. Prologis, Inc. (PLD): Analyst Thomas Catherwood’s $155 target reflects confidence in the stock’s October breakout. With support at $124-$125, BTIG sees potential for resumed uptrend, especially if it breaks above the $136 resistance level.
Prologis, Inc. priced an offering of C$700 million in notes due 2032. The company also received a price target increase to $155.00 from BTIG, which cited improved fundamentals.
8. Rocket Companies, Inc. (RKT): Analyst Eric Hagen sets a $25 target for this stock, which has been building a base after a significant 2021-2022 decline. Key resistance sits at $21.50-$22, with room to $25-$27 above that level.
Rocket Companies, Inc. announced third-quarter adjusted revenue of $1.78 billion and adjusted earnings per share of $0.07, both surpassing consensus estimates. Separately, Jefferies initiated coverage on the company with a Buy rating.
9. Spire, Inc. (SR): With a $99 target from analyst Alex Kania, this stock broke out in September after six months of consolidation. Currently holding above its 200-day moving average ($78.63), BTIG anticipates the uptrend will continue.
Spire, Inc. issued $900 million in notes to finance its acquisition of a Tennessee natural gas business. The company also received an upgrade to Overweight from Morgan Stanley, which cited an outlook for above-average EPS growth.
10. TKO Group Holdings, Inc. (TKO): Analyst Tyler DiMatteo assigns a $250 target to this stock, which recently found support above its rising 200-day moving average before pushing to new highs. With no natural resistance at all-time highs, BTIG projects potential movement toward $250 as long as the uptrend holds.
TKO Group Holdings, Inc. received price target increases from multiple firms, with BTIG raising its target to $250 and TD Cowen increasing its target to $245.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
